Carbon monoxide–releasing molecule-3: Amelioration of renal ischemia reperfusion injury in a rat model
暂无分享,去创建一个
Su-Jin Shin | Sung Yul Park | Jiyoung Lee | D. K. Kim | H. Moon | H. Choi | Y. Kim | Y. Yoon
[1] Colin H. Wilson,et al. Machine perfusion preservation versus static cold storage for deceased donor kidney transplantation. , 2019, The Cochrane database of systematic reviews.
[2] M. Nicholson,et al. Ischemia-reperfusion injury in renal transplantation: 3 key signaling pathways in tubular epithelial cells. , 2019, Kidney international.
[3] N. Selzner,et al. PPAR-gamma activation is associated with reduced liver ischemia-reperfusion injury and altered tissue-resident macrophages polarization in a mouse model , 2018, PloS one.
[4] Xi Chen,et al. The Role of Peroxisome Proliferator-Activated Receptor γ in Mediating Cardioprotection Against Ischemia/Reperfusion Injury , 2018, Journal of cardiovascular pharmacology and therapeutics.
[5] Bo-Hwa Choi,et al. Near-Normalized Gene Expression Profiles in Bladder With Detrusor Overactivity in Rats With Bladder Outlet Obstruction After Deobstruction , 2017, International neurourology journal.
[6] A. Zumrutbas,et al. The renoprotective effects of mannitol and udenafil in renal ischemia-reperfusion injury model , 2017, Investigative and clinical urology.
[7] L. Gunaratnam,et al. Hydrogen Sulfide Treatment Mitigates Renal Allograft Ischemia-Reperfusion Injury during Cold Storage and Improves Early Transplant Kidney Function and Survival Following Allogeneic Renal Transplantation. , 2015, The Journal of urology.
[8] K. Lee,et al. Renoprotective Mechanism of Remote Ischemic Preconditioning Based on Transcriptomic Analysis in a Porcine Renal Ischemia Reperfusion Injury Model , 2015, PloS one.
[9] J. Kaouk,et al. Minimally invasive partial nephrectomy in the age of the ‘trifecta’ , 2015, BJU international.
[10] H. Pazoki-Toroudi,et al. ATP-dependent potassium channels are implicated in simvastatin pretreatment-induced inhibition of apoptotic cell death after renal ischemia/reperfusion injury , 2015, Medical journal of the Islamic Republic of Iran.
[11] S. Ryter,et al. Carbon monoxide: present and future indications for a medical gas , 2013, The Korean journal of internal medicine.
[12] Jie Cai,et al. "Trifecta" in partial nephrectomy. , 2013, The Journal of urology.
[13] G. Janetschek,et al. Cooling mechanisms in laparoscopic partial nephrectomy: are really necessary? , 2013, Archivos españoles de urología.
[14] A. Şener,et al. Detrimental effects of prolonged warm renal ischaemia‐reperfusion injury are abrogated by supplemental hydrogen sulphide: an analysis using real‐time intravital microscopy and polymerase chain reaction , 2012, BJU international.
[15] A. Shokeir,et al. Role of combination of l‐arginine and α‐tocopherol in renal transplantation ischaemia/reperfusion injury: a randomized controlled experimental study in a rat model , 2011, BJU international.
[16] G. Ogaya‐Pinies,et al. Intravenous sildenafil as a preconditioning drug against hemodynamic consequences of warm ischemia-reperfusion on the kidney. , 2011, The Journal of urology.
[17] Hao Wang,et al. Carbon monoxide-releasing molecules protect against ischemia-reperfusion injury during kidney transplantation. , 2011, Kidney international.
[18] L. Otterbein,et al. Intraoperative Administration of Inhaled Carbon Monoxide Reduces Delayed Graft Function in Kidney Allografts in Swine , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[19] L. Otterbein,et al. The therapeutic potential of carbon monoxide , 2010, Nature Reviews Drug Discovery.
[20] Inderbir S Gill,et al. Every minute counts when the renal hilum is clamped during partial nephrectomy. , 2010, European urology.
[21] D. Stolz,et al. Carbon Monoxide Ameliorates Renal Cold Ischemia-Reperfusion Injury With an Upregulation of Vascular Endothelial Growth Factor by Activation of Hypoxia-Inducible Factor , 2008, Transplantation.
[22] E. Mazzon,et al. ROLE OF ENDOGENOUS PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-α (PPAR-α) LIGANDS IN THE DEVELOPMENT OF GUT ISCHEMIA AND REPERFUSION IN MICE , 2006 .
[23] E. Mazzon,et al. ROLE of endogenous peroxisome proliferator-activated receptor-alpha (PPAR-alpha) ligands in the development of gut ischemia and reperfusion in mice. , 2006, Shock.
[24] G. Lopaschuk,et al. Chronic activation of PPARalpha is detrimental to cardiac recovery after ischemia. , 2006, American journal of physiology. Heart and circulatory physiology.
[25] G. Lopaschuk,et al. Chronic activation of PPARα is detrimental to cardiac recovery after ischemia , 2006 .
[26] R. Foresti,et al. Therapeutic applications of carbon monoxide-releasing molecules , 2005, Expert opinion on investigational drugs.
[27] H. Drummond,et al. Protective effect of carbon monoxide-releasing compounds in ischemia-induced acute renal failure. , 2005, Journal of the American Society of Nephrology : JASN.
[28] R. Foresti,et al. Bioactivity and pharmacological actions of carbon monoxide-releasing molecules. , 2003, Current pharmaceutical design.
[29] N. Patel,et al. Rosiglitazone and 15‐deoxy‐Δ12,14‐prostaglandin J2, ligands of the peroxisome proliferator‐activated receptor‐γ (PPAR‐γ), reduce ischaemia/reperfusion injury of the gut , 2003 .
[30] W. Wahli,et al. Peroxisome proliferator-activated receptor-beta signaling contributes to enhanced proliferation of hepatic stellate cells. , 2003, Gastroenterology.
[31] N. Patel,et al. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut. , 2003, British journal of pharmacology.